Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HIV maturation is a critical, late-stage process in the HIV-1 life cycle that transforms newly budded, immature, and noninfectious viral particles into mature, infectious virions. This transformation is driven by the proteolytic cleavage of the Gag and Gag-Pol polyproteins by the viral protease (PR), resulting in dramatic structural rearrangements within the virus particle. Successful HIV maturation is essential for infectivity, and defects or inhibition lead to the production of noninfectious virions.
Inhibition of HIV protease prevents cleavage of Gag and Gag-Pro-Pol polyproteins; maturation inhibitors block processing steps at CA-SP1 junction
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HIV Maturation.